Related Experiment Video
Updated: Jul 20, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Clinical features of 162 fatal cases of COVID-19: a multi-center retrospective study
Xianlong Zhou1, Guoyong Ding2, Qing Fang3
1Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Insights
Fatal COVID-19 cases predominantly affected older males, often with hypertension. However, even younger patients without comorbidities could experience severe outcomes, highlighting the unpredictable nature of the disease.
Area of Science:
- Medicine
- Infectious Diseases
- Public Health
Background:
- Limited data existed on fatal cases of coronavirus disease 2019 (COVID-19), despite its global impact.
- Understanding the characteristics of fatal COVID-19 cases is crucial for public health strategies.
Purpose of the Study:
- To describe the clinical features of 162 fatal coronavirus disease 2019 (COVID-19) cases.
- To analyze demographic data, symptoms, comorbidities, and treatment outcomes in deceased COVID-19 patients.
Main Methods:
- Retrospective review of electronic medical records for 162 fatal COVID-19 cases.
- Data collected included demographics, clinical presentation, comorbidities, laboratory results, CT scans, treatments, and complications.
Main Results:
- The median age of deceased patients was 69.5 years, with 80% over 61. Men comprised 69.1% of fatalities.
- Hypertension was the most common comorbidity (45.1%), though 36.4% had no prior conditions.
- Most patients presented with severe or critical COVID-19, with 93.2% developing respiratory failure or ARDS. Mechanical ventilation was common, often preceding ICU admission.
Conclusions:
- Fatal outcomes can occur in younger COVID-19 patients without comorbidities.
- In-hospital survival times for fatal cases were consistent across different hospital levels in Wuhan.
Background:
The coronavirus disease 2019 (COVID-19) has affected approximately 2 million individuals worldwide; however, data regarding fatal cases have been limited.
Objective:
To report the clinical features of 162 fatal cases of COVID-19 from 5 hospitals in Wuhan between December 30, 2019 and March 12, 2020.
Methods:
The demographic data, signs and symptoms, clinical course, comorbidities, laboratory findings, computed tomographic (CT) scans, treatments, and complications of the patients with fatal cases were retrieved from electronic medical records.
Results:
The median patient age was 69.5 (interquartile range: 63.0-77.25) years, and 80% of the patients were over 61 years. A total of 112 (69.1%) patients were men. Hypertension (45.1%) was the most common comorbidity, while 59 (36.4%) patients had no comorbidity. At admission, 131 (81.9%) patients had severe or critical COVID-19, whereas 39 (18.1%) patients with hypertension or chronic lung disease had moderate COVID-19. In total, 126 (77.8%) patients received antiviral treatment, while 132(81.5%) patients received glucocorticoid treatment. A total of 116 (71.6%) patients were admitted to the intensive care unit (ICU), and 137 (85.1%) patients received mechanical ventilation. Most patients received mechanical ventilation before ICU admission. Approximately 93.2% of the patients developed respiratory failure or acute respiratory distress syndrome. There were no significant differences in the inhospital survival time among the hospitals (P=0.14).
Conclusion:
Young patients with moderate COVID-19 without comorbidity at admission could also develop fatal outcomes. The in-hospital survival time of the fatal cases was similar among the hospitals of different levels in Wuhan.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis
Single Nucleotide Polymorphisms-SNPs
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

